GSK Exceeds Earnings and Revenue Estimates, Maintains Long-Term Outlook
GlaxoSmithKline (GSK) reported Q1 Non-GAAP earnings per share of £0.465, surpassing expectations by £0.03, and revenue of £7.63 billion, beating forecasts by £20 million. The company reaffirmed its FY26 and 2031 financial outlook despite strong performance in several key sectors.
Tickers: $GSK